September 10, 2025

Realizing the Full Potential of Patient Engagement in Clinical Research

Nothing about us without us is a centuries-old value that is a cornerstone of meaningful patient engagement in clinical research. Such engagement has not been automatic and is still largely absent in ...

The ASCO Post

September 04, 2025

Is This the End of Cancer Research as We Know It?

Ongoing efforts to rein in government spending have been described as a “chainsaw for bureaucracy.” It’s an apt metaphor for the haphazard budget cuts that many federal agencies are still experiencing...

The ASCO Post

August 29, 2025

How to Adapt to the Era of AI and the Changing Interactions With Patients: Lessons From a Low-Resource Setting

After 2 decades of practicing medicine across multiple disciplines and health systems, I’ve witnessed the dramatic transformation of patient-physician interactions, and none more dramatic than what I’...

The ASCO Post

August 22, 2025

Smoking Cessation in Cancer Care: Challenges and Opportunities

Smoking was found to worsen both cancer symptom burden and severity, and oncologic surgery may represent a unique teachable moment for smoking cessation, as patients appeared to be highly motivated to...

The ASCO Post

August 22, 2025

Does Preexisting Depression Impact Prostate Cancer Survival?

Based on the results of an analysis reported in JAMA Network Open by Zhang et al, preexisting depression is associated with an increased risk of mortality from prostate cancer.

The ASCO Post

July 10, 2023

Expert Point of View: Pamela L. Kunz, MD and Corrie Marijnen, MD, PhD

Dr. Pamela L. Kunz and Dr. Corrie Marijnen discuss the groundbreaking PROSPECT trial, highlighting the safe omission of radiation in many patients with advanced rectal cancer, improving quality of life and reducing side effects.

The ASCO Post

March 27, 2024

Intravenous Cetirizine Premedication to Mitigate Infusion-Related Reactions

Discover how a 62-year-old woman's paradoxical reaction during paclitaxel chemotherapy led to a substitution of intravenous diphenhydramine with intravenous cetirizine, highlighting the complexities of managing infusion-related reactions.

JADPRO

January 25, 2023

Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

Physicians tackle challenges discussing prognosis due to inadequate formal training and the discomfort of the conversations. Redefining prognosis can alleviate patients' fears about the future. Click to learn evidence-based tools for better communication.

The ASCO Post

February 05, 2025

The Role of Human Leukocyte Antigens in Reducing Lung Cancer Risk

With findings that human leukocyte antigen-II (HLA-II) heterozygosity is associated with reduced risk of developing lung cancer, with particular benefits to smokers, Mount Sinai researchers add evidence to the theory of the immune system's protective function against cancer.

Mount Sinai New York